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ABSTRACT
Epstein-Barr virus (EBV)-encoded latent membrane protein 1 (LMP1), which is expressed during viral latency, has oncogenic properties that are associated with several malignant diseases. The purpose of this study is to examine how the ethanolic extract from Polygonum
cuspidatum root (PcE) inhibits the functions of latent membrane protein 1. We found that the viability of EBV-positive cells, B95-8 cells
decreased in a time- and dose-dependent manner after the cells were treated with PcE. Furthermore, PcE inhibited the transcription of
the LMP1 gene, BNLF1. This was attributed to the inhibition of the expression of Rta, which are known to activate the transcription of
BNLF1. Flow cytometry analysis showed that PcE caused an increase in the number of B95-8 cells that were arrested at the sub-G1 phase
and displayed typical features of apoptosis. In other words, PcE promoted B95-8 cells apoptosis due to its ability to inhibit the expression
of latent membrane protein 1 and deplete NF-κB in the nucleus. These results indicated that PcE may be a useful therapeutic drug to kill
cells that are infected by EBV.
Key words: Epstein-Barr virus, Polygonum cuspidatum, latent membrane protein 1

INTRODUCTION
Epstein-Barr virus (EBV) is an oncogenic human
herpesvirus, which infects B lymphocytes and epithelial
cells(1). Although the infection is often asymptomatic, it
causes infectious mononucleosis and is associated with
several human malignancies, including Burkitt’s(2) and Hodgkin’s lymphomas(3) nasopharyngeal carcinoma (NPC)(4) and
gastric carcinoma(5). EBV gene expression differs among
malignancies associated with the virus. EBV in Burkitt’s
lymphoma tissues usually have a type-I latency pattern with
expression of EBNA-1 but not the other latency-associated
proteins. EBV in tissues from patients with Hodgkin’s
lymphomas and nasopharyngeal carcinoma has a type-II
latency pattern with expression of EBNA (EBV nuclear
antigen) 1, LMP (latent membrane protein) 1 and LMP2.
EBV in immunocompromised patients with EBV lympoproliferative disease generally have a type-III latency pattern and
express EBNA1, EBNA2, EBNALP, EBNA3A, EBNA3C,
LMP1, LMP2A and LMP2B(6). The EBV-encoded LMP1 is
an integral membrane protein that has been known to have
oncogenic properties during latent infection(7).
* Author for correspondence. Fax:+886-62667327;
E-mail: tplin007@mail.chna.edu.tw
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Transcription of the LMP1 gene, BNLF1, is initiated
from a proximal promoter, ED-L1, and a distal promoter,
TR-L1(8). These two promoters are regulated by EBNA1(9)
and lytic protein, Rta(10). Meanwhile, the ED-L1 promoter
is activated by EBNA2(11) and NF-κB(12). LMP1 also activates the function of NF-κB, which is a key modulator of cell
growth and relevant to the oncogenic role of EBV in some
malignant tumors(13). NF-κB that is bound to its inhibitory
protein IκBs is retained in the cytosolic compartment(14).
Following activation, IκBs are phosphorylated by IκB
kinases and subsequent degradation of phosphorylated IκBs
allows translocation of NF-κB into the nucleus and binding to
their cognate DNA-binding sites to regulate the transcription
of a large number of genes including antimicrobial peptides,
cytokines, chemokines, stress response proteins, and antiapoptotic proteins(14). In other words, NF-kB plays a critical
role in LMP1-mediated signal transduction, involves in the
regulation of cell apoptosis, cell cycle and carcinogenic transformation. Although the treatment for some EBV-associated
malignancies has improved in recent years, new approaches
to therapy are needed.
Polygonum cuspidatum Sieb. et Zucc. (P. cuspidatum)
is used for the treatment of various inflammatory diseases,
hepatitis and tumors in eastern Asian countries(15). It had
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been reported that the methanolic extract of P. cuspidatum
contains various compounds including piceid, resveratrol,
anthraglycoside B, emodin and physcion(16). Our earlier work
revealed that the ethanolic extract of P. cuspidatum (PcE)
inhibited the expression of EBV lytic proteins, including, Rta,
Zta and EA-D(17). Moreover, resveratrol, the major component of PcE, has the antiviral activity to inhibit the expression
of EBV lytic proteins, including Rta, Zta and EA-D(18). This
study found that PcE inhibits the expression of LMP1 and
triggers EBV-positive cells toward apoptosis.

V. Immunoblot Analysis
Cell lysate was prepared from 3 × 106 B95-8 cells with
100 μL of lysis buffer that contained 50 mM Tris-HCl, pH
7.8, 150 mM NaCl, 5 mM EDTA, 0.5% Triton X-100 and
0.5% NP40 using a method described elsewhere(21). SDSpolyacrylamide gel electrophoresis and immunoblot analysis using anti-Rta and anti-LMP1 antibodies, which were
purchased from Argene (Varilhes, France) and Thermo Scientific (CA, USA), respectively, were performed according to
the methods described elsewhere(22). The intensities of the
bands were quantitated by scanning densitometry.

MATERIALS AND METHODS
VI. Transient Transfection and Luciferase Assay
I. Materials
P. cuspidatum was collected from the San-Dei-Men area
in Pingtung County, Taiwan and verified by Prof. C. S. Kuoh.
The specimen was deposited in the herbarium of the National
Cheng Kung University, Tainan, Taiwan.
II. Extraction of P. cuspidatum
Ten grams of dried powder from the P. cuspidatum root
was extracted three times in 100 mL of ethanol by refluxing
at 85°C for 2 h. After each extraction, the ethanol fraction
was collected by filtration. The ethanol was then removed by
rotary evaporation and a yield of 21.6% was obtained. The
resulting residues were finally dissolved in dimethyl sulfoxide (DMSO).
III. Cell Culture and Lytic Induction of EBV
B95-8 is a cotton-top tamarin B cell line immortalized by
an EBV strain from a patient with infectious mononucleosis.
P3HR1 is a Burkitt’s lymphoma cell line which is latently
infected by EBV, showing no detectable LMP1. These cells
were obtained from Prof. S. T. Liu of Chang-Gung University. All cells were cultured in RPMI 1640 medium containing
10% fetal calf serum (Biological Industries, Israel). Cells
were treated with 3 mM of sodium butyrate (SB) or 30 ng/mL
of TPA to induce the EBV lytic cycle(19).
IV. Cell Viability Assay
The MTT [3-(4,5-dimethyldiazol-2-yl)-2,5 diphenyl
tetrazolium bromide] assay was used to assess the effects of
PcE on B95-8 cell viability. The assay relies on the production
of a colored formazan by the action of mitochondrial dehydrogenase on MTT(20). Briefly, 0.5 mg/mL solution of MTT
in RPMI 1640 medium was added into 1 × 105/mL B95-8
cells for 4 h at 37°C. The dark blue crystals were dissolved
by DMSO. The plates were read on an ELISA reader using
a wavelength of 492 nm. Cell survival was calculated as a
percentage of MTT inhibition by the following formula:
Relative Cell Viability (%) = (Mean Experimental Absorbance/Mean Control Absorbance) × 100%
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P3HR1 cells (5 × 106) were transfected with 10 μg of
TR-L1-Luc with a Bio-Rad electroporator using the method
of Chang et al.(23,24) Cells were harvested at 24 h after transfection, and luciferase activity was determined using a luminometer (Berthold, Germany).
VII. Indirect Immunofluorescence Analysis and DAPI
Staining of Apoptotic Cells
B95-8 cells were plated on poly-L-lysine-coated overslips and fixed with 4% paraformaldehyde at 4°C for 15 min,
followed by treatment with PBS containing 0.5% Triton
X-100 for 10 min at room temperature. After blocking with
1% BSA in PBS at room temperature for 30 min, monoclonal
anti-NF-κB p65 antibodies (Cell signaling, Beverly, MA)
were applied at a dilution of 1 : 50 and incubated at room
temperature for 1 h. Next, the cells were washed with PBS
and incubated with the CY3-conjugated anti-IgG (Sigma) for
1 h. After counterstaining with 4’,6’-diamidio-2-phenylindole
(DAPI), the cells were examined under a fluorescence microscope. The cells were stained with DAPI to reveal apoptotic
cells. Nuclear morphology was visualized at 400x under a
fluorescence microscope.
VIII. Flow Cytometric Analysis
Flow cytometry was performed to quantitatively detect
the apoptotic rate. To determine the stages of the cell cycle, the
cells after treatment of PcE were harvested, washed and fixed
in 70% ethanol overnight at 4°C, and stained with propidium
iodide. The sub-G1 peak was measured with a flow cytometer
(Model FACScanTO, BD Biosciences) and analyzed using
Cell Quest software (BD Biosciences).
IX. Statistical Analysis
Data were analyzed statistically by one-way analysis of
variance (ANOVA) using the SAS JMP 6.0 software package.
Values were presented as means ± S.D. and a p value of less
than 0.05 was regarded as significant.
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RESULTS
I. Inhibitory Effect of PcE on the Growth of B95-8 Cells
To determine the effects of PcE on B95-8 cells, which
is an EBV-positive B cell line with a type III latency pattern.
The cells were treated with various concentrations of PcE for
one, three or six days. The viability of the cells was measured
by the MTT assay. PcE at the concentration of 100 μg/mL
killed 24% of B95-8 cells after one day of culturing. Three
days after treatment, the viability of B95-8 cells decreased
when they were treated with PcE (range, 25-100 μg/mL) in a
dose-dependent manner. PcE decreased cell viability to 50%
(CC50) at 76 μg/mL. PcE exhibited a more cytotoxic effect
on B95-8 cells on six days after treatment. These results
indicated that the cell viability decreased in dose and timedependent fashions (Figure 1).
II. Inhibition of the Expression of EBV Encoded Rta and
Latent Membrane Protein 1 by PcE
Previous studies showed that PcE inhibited the expression of EBV lytic genes in P3HR1 cells(17). To determine
whether PcE inhibited the expression of Rta in B95-8 cells,
B95-8 cells (6 × 105/mL) were treated with PcE before lytic
induction for 24 h. The results showed that PcE at concentrations of 12.5 and 50 μg/mL inhibited the expression of Rta by
50 and 90%, respectively (Figure 2A). EBV-encoded LMP1
affected cell proliferation, transformation, anti-apoptosis
and immortalization(13). PcE had a cytotoxic effect towards
B95-8 cells and inhibited the expression of Rta. Moreover,
it had been documented that the lytic protein, Rta, promoted
the transcription of LMP1 TR-L1 promoter and induced the
expression of LMP1(10). Therefore, we will elucidate whether
PcE affected the expression of LMP1. After treating the
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6 days

Relative cell viability (%)

100

III. Inhibition of the Transcriptional Activity of LMP1
Promoter, TR-L1
Transient transfection was performed to explore whether
PcE influenced the transcription of the LMP1 promoter.
Reporter plasmid, TR-L1-Luc, which contained a firefly
luciferase gene transcribed from the LMP1 promoter, TR-L1,
were transfected into P3HR1 cells, and then treated with PcE
before lytic induction for 24 h. Upon analyzing the luciferase
activity exhibited by the cells, it was observed that PcE at
25 μg/mL suppressed the transcriptional activity of the LMP1
promoter which was induced by sodium butyrate, by 70%,
and PcE at at 50 μg/mL inhibited the transcriptional activity
of the LMP1 promoter by 90% (Figure 3).
IV. Translocation of NF-kB Inhibited by PcE
It is well documented that LMP1 can activate the NF-κB
signal pathway. NF-κB is a transcriptional factor, which can
regulate cell growth and is also an anti-apoptotic protein(14).
In this study, we demonstrated that PcE reduced the expression of LMP1. Thus, we will investigate the subcellular
location of transactivated p65 subunit at PcE treatment by
indirect immunofluorescence assay. An antibody specific to
the p65 subunit of NF-κB was detected with high immunoreactivity in the cytoplasm and nucleus. PcE at 50 μg/mL
depleted NF-κB (p65) in the nuclei of B95-8 cells after 24 h
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Figure 1. Effect of PcE on the growth of B95-8 cells. The B95-8 cells
were treated with PcE for 1, 3 and 6 days. Relative cell viability was
determined by MTT assay. The data were presented as mean ± S.D.
from three independent experiments. *p < 0.05, which represents a
significant difference from the values of the control group.
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B95-8 cells (6 × 105/mL) with various concentrations of PcE
for 24 h, the expression of LMP1 was performed by immunoblots. The results showed that 50 μg/mL of PcE reduced
the expression of LMP1 by 40%, and 100 μg/mL of PcE
completely inhibited the expression of LMP1 (Figure 2B).

Figure 2. Inhibition of latent membrane protein 1 (LMP1) and lytic
protein Rta expression by PcE. For the analysis of EBV lytic protein
Rta expression (A), PcE was added to B95-8 cells before lytic induction with TPA (30 ng/mL) and SB (3 mM). After 24 h of culturing,
the immunoblotting assay was performed using anti-Rta and b-actin
monoclonal antibodies. For LMP1 expression assay (B), B95-8 cells
were treated with PcE (A) for 24 h. The immunoblotting assay was
performed using anti-LMP1 and b-actin monoclonal antibodies.
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of treatment (Figure 4). The results indicated that the p65
subunit was barely detectable in the nuclei following 24 h of
incubation with PcE.
V. PcE Induces B95-8 Cells Apoptosis
It has been demonstrated that PcE reduced the expression
of LMP1 and depleted the NF-κB in the nuclei of B95-8 cells.
To determine whether PcE induced B95-8 cells apoptosis,
B95-8 cells were treated with various concentrations of PcE

Relative luciferase activity (%)

120
100

for 72 h. DAPI staining was performed to detect apoptosis.
Under fluorescence microscopy, the cells without PcE treatment showed normal spherical nuclei and uniform chromatin
distribution, and the cells treated with 50 and 100 μg/mL PcE
exhibited typical features of apoptosis-chromatin condensation and nuclear fragmentation (Figure 5).
Further, we quantified the apoptotic cell after PcE
treatment. B95-8 cells were treated with various concentrations of PcE for 72 h, and apoptotic nuclei were identified
in the subdiploid region (sub-G1) of the histograms by flow

Control

PcE 25

PcE 50

PcE 100

TR-L1-Luc

80
60
40
20
0
Control

SB

25

50

100

SB+PcE (μg/mL)
Figure 3. Transcriptional inhibition of LMP1 promoter by PcE in
P3HR1 cells. P3HR1 cells were transfected with TR-L1-Luc plasmid,
and then treated with sodium butyrate (SB) and PcE (25 - 100 μg/mL).
Luciferase activity was measured by a luminometer at 24 h after treatment. The data were presented as mean ± S.D. from three independent
experiments. *p < 0.05, which represents a significant difference from
the values of the SB group.

Figure 5. Apoptosis characteristic of B95-8 cells induced by PcE.
B95-8 cells were treated with PcE (25-100 μg/mL) for 3 days. The
nuclei were characterized by using DAPI staining and then photographed by fluorescent microscopy.
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Figure 4. Inhibition of nuclear localization of activated p65. B95-8 cells were treated with PcE (25 - 100 μg/mL) for 24 h. NF-κB localization was
detected using a fluorescence-labeled anti–NF-κB p65 antibody and nuclear staining by DAPI.
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cytometry using PI staining. The rate of cells undergoing
apoptosis (sub-G1) in B95-8 cells treated with 50 and 100
μg/mL of PcE increased from 2.6 to 12.07% and 15.62%,
respectively (Figure 6).

DISCUSSION
It has been well established that the combination of lytic
EBV infection and certain antiviral agents can enhance the
killing of EBV-positive tumor cells, such as using sodium
butyrate(25,26) or NF-κB inhibitor, aspirin(27) and combined
with GCV to induce lytic cytotoxicity in EBV-positive cells,.
On the other hand, interfering with LMP1 expression by
siRNA(28,29), DNAzymes(30) and arsenic trioxide(31) have
also been demonstrated to induce apoptosis of EBV-positive
lymphoma cells and NPC cells. Additionally, Epigallocatechin-3-gallate not only inhibits the growth of nasopharyngeal
carcinoma cells, but also blocks LMP1-caused NF-κB activation mediated via interfering with the phosphorylation of
IκBa(32). This study showed that PcE inhibits the expression

of latent membrane protein 1 and triggers EBV-positive cells
toward apoptosis.
For B95-8 cells treated with PcE (range, 25-100 μg/mL),
the cell viability was decreased in a dose-dependent manner
on the third day after treatment. At 50 μg/mL, PcE significantly inhibited the expression of LMP1 and transcriptional
activity of LMP1 promoter by decreasing the expression of
Rta protein. Furthermore, PcE reduced the translocation of
NF-κB from the cytoplasm to the nuclei and promoted chromatin condensation, marginal and nuclear fragmentation.
The rate of cells undergoing apoptosis in B95-8 increased
to five fold. In other words, PcE depleted NF-κB in the
nuclei of B95-8 cells by decreasing the expression of LMP1
and induced apoptosis of EBV-positive cells. In previous
studies, we had demonstrated that PcE inhibited the expression of EBV lytic proteins including, Rta, Zta and EA-D and
reduced the production of virus particles(17). Therefore, PcE
may represent a novel strategy for the treatment of EBVassociated lymphomas.
Moreover, PcE contains resveratrol and emodin(17).
Previous studies have documented that resveratrol has

Control

PcE 25

200

200

sub-G1 3.32%

Cell number

Cell number

sub-G1 2.60%

M1

M1

0

0

DNA content

200

0

1023

PcE 50

0

sub-G1 15.62%

Cell number
DNA content

1023

PcE 100

M1

0

DNA content

200

sub-G1 12.07%

Cell number

0

M1

1023

0

0

DNA content

1023

Figure 6. Cell cycle distributions of B95-8 cells were analyzed by flow cytometric analysis. The cells were treated with PcE for 3 days, and then
stained with PI solution to assess the cell cycle distribution pattern. The percentage of sub-G1 phase over total cells was calculated and expressed
on each histogram.
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the antiviral activity to inhibit the expression of EBV lytic
proteins, including Rta, Zta and EA-D(18). It also inhibits
the DNA replication of the human cytomegalovirus(33) and
herpes simplex virus(34), and promotes the apoptosis of
human oral epidermoid carcinoma KB cells(35) and Burkitt’s
lymphoma cells(36) by blocking NF-κB transcription factor
activation. Emodin induces the apoptosis of human lung
adenocarcinoma cells(37), gallbladder cancer cells(38), prostate cancer cells(39) and hepatocellular carcinoma cells(40)
through reactive oxygen species (ROS) production. Therefore, we propose that the major component, resveratrol, may
be involved in PcE-induced apoptosis of B95-8 cells through
decreasing the expression of LMP1 and depleting NF-κB in
nuclei of B95-8 cells. Besides, emodin may have participated
in PcE and promoted the B95-8 cells apoptosis mediated via
the generation of ROS.

CONCLUSIONS
This study demonstrated that PcE inhibited the expression of latent membrane protein 1 and induced the apoptosis
of B95-8 cells. The resulted indicated that PcE may be a
useful therapeutic drug for EBV-positive lymphoma cells.
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